Matt, Author at European Medical Journal - Page 187 of 212

March Madness

You blink once, and it’s the beginning of 2017. You blink again, and March is here, eagerly knocking on the door to announce its arrival after what feels…

New Drug Treatments for Osteoarthritis: What Is on the Horizon?

Osteoarthritis (OA) is the most common form of arthritis, yet has historically lagged far behind rheumatoid arthritis in terms of drug development.

Antiphospholipid Syndrome and the Lungs

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by recurrent thromboembolic events (arterial or venous) and/or morbidity…

This February, EMJ Supports

For the European Medical Journal (EMJ), the beginning of each month provides an opportunity for us to showcase the medical campaigns we select to support…

From EMJ With Love

As February draws to a close, the team here at EMJ are wondering where the time has gone as we busily prepare innovative content for our avid readers!

The Evolving Treatment of Clostridium Difficile Infection

Clostridium difficile infection (CDI) rates have been increasing, with a corresponding rise of morbidity and mortality. The primary treatment modality of…

New Developments for Parkinson’s Therapy with COMT Inhibitors

Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. There are currently…

EMJ Weekly News Round-Up: 27th January

Your EMJ weekly news round-up. In the news, this week: Artificial intelligence detecting skin cancer in clinical images, brain scans used to predict…

New Year, New Content!

WITH THE CHRISTMAS HOLIDAYS a mere twinkle of a memory, the festive season has well and truly been and gone, finding ourselves settled into January.

EMJ Weekly News Round-Up: 16th January

Hello and welcome to your EMJ weekly news round-up. This week: A database helping researchers reduce the number of animals used in research, modafinil…